Study of PD-1 Inhibitor Combination With Autologous Cell Immunotherapy in the Metastatic Renal Cell Carcinoma
Condition(s):Renal Cell Carcinoma; Clear Cell Renal Cell CarcinomaLast Updated:July 7, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Renal Cell Carcinoma; Clear Cell Renal Cell CarcinomaLast Updated:July 7, 2020Unknown status
Condition(s):Kidney NeoplasmsLast Updated:October 30, 2018Withdrawn
Condition(s):Papillary Renal Cell CarcinomaLast Updated:November 29, 2023Not yet recruiting
Condition(s):Adenocarcinoma of the Bladder; Distal Urethral Cancer; Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter; Proximal Urethral Cancer; Recurrent Bladder Cancer; Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter; Recurrent Urethral Cancer; Squamous Cell Carcinoma of the Bladder; Stage III Bladder Cancer; Stage III Urethral Cancer; Stage IV Bladder Cancer; Transitional Cell Carcinoma of the Bladder; Urethral Cancer Associated With Invasive Bladder CancerLast Updated:October 20, 2014Completed
Condition(s):Clear Cell Renal Cell Carcinoma; Recurrent Renal Cell Cancer; Stage III Renal Cell Cancer; Stage IV Renal Cell CancerLast Updated:January 13, 2016Completed
Condition(s):Clear Cell Renal Cell Carcinoma; Recurrent Renal Cell Carcinoma; Stage IV Renal Cell CancerLast Updated:September 16, 2016Completed
Condition(s):Breast Neoplasms; Peritoneal Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Stomach NeoplasmsLast Updated:September 30, 2016Completed
Condition(s):Stage IV Melanoma; Stage IV Renal Cell Cancer; Recurrent Renal Cell Cancer; Recurrent MelanomaLast Updated:March 4, 2024Completed
Condition(s):Metastatic Renal Cell CarcinomaLast Updated:May 18, 2021Unknown status
Condition(s):Renal Cell CarcinomaLast Updated:March 8, 2011Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.